F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview, medical record review, and facility P&P review, the facility failed to provide the necessary care
and services for one of ninesampled residents (Resident 2).
Residents Affected - Few
* The facility failed to timely provide and administer Resident 2's medications as per the physician's orders
on 11/26 and 11/27/24.
* The facility failed to follow up and notify the physician regarding Resident 2 of not receiving his
medications due to pending delivery status of the ordered medications.
These failures had the potential to negatively affect the resident's health condition and well-being.
Findings:
Review of the facility's P&P titled Prescriber Medication Orders dated 1/2019 showed the prescriber shall
be contacted for direction when delivery of a medication will be delayed, or medication is not available. new
medications except for emergency or stat medications are ordered as follows: the first dose of medication is
scheduled to be given after the next regularly scheduled pharmacy delivery to the care center. If needed
before the next regular delivery, inform the pharmacy of the need for prompt delivery. Timely delivery of new
orders is required so that medication is not delayed. If available, the emergency kit is used when the
residents needs a medication prior to pharmacy delivery.
Closed medical record review for Resident 2 was initiated on 12/6/24. Resident 2 was admitted to the
facility on [DATE] and transferred to the acute care facility on 12/2/24. Resident 2 had diagnoses including
Type II DM, HTN, and HLD.
Review of Resident 2's H&P examination dated 11/26/24, showed Resident 2 had fluctuating capacity to
understand and make decisions.
a. Review of Resident 2's Order Summary Report dated 11/25/24, showed the following physician's orders:
- alfuzosin HCL (antihypertensive medication)ER tablet 10 mg, give one tablet one time a day for benign
prostate hyperplasia (BPH)
- aspirin EC (NSAID) tablet delayed release 81 mg, give one tablet one time a day for CVA prophylaxis
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 9
Event ID:
055689
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
- atorvastatin calcium (antilipidemic medication) oral tablet 80 mg, give one tablet one time a day for HLD
Level of Harm - Minimal harm
or potential for actual harm
- escitalopram oxalate (antidepressant medication) tablet 20 mg, give 0.5 mg tablet one time a day for
depression
Residents Affected - Few
- ezetimibe tablet (antilipemic medication) 10 mg, give one tablet by mouth at bedtime for HLD
- finasteride tablet (medication to treat enlarged prostate) 5 mg, give one tablet one time a day for BPH
- glipizide (anti-diabetic) tablet 10 mg, give one tablet by mouth one time a day for diabetes before meals
- losartan potassium (antihypertensive medication)oral tablet 25 mg, give one tablet by mouth one time a
day for HTN
- protonix tablet (treat high levels of stomach acid) delayed release 40 mg, give one tablet by mouth one
time a day for GERD before breakfast
- sitagliptin phosphate (anti-diabetic) tablet 50 mg, give one tablet by mouth one time a day for DM
- carvedilol (antihypertensive medication) oral tablet 6.26 mg, give 0.5 mg by mouth two times a day for
hypertension
Review of Resident 2's MAR for November 2024 showed the following medications were coded as 7 (other,
see nurses notes).
- alfuzosin HCL ER tablet 10 mg one tablet one time a day
- aspirin EC tablet delayed release 81 mg one tablet one time a day
- atorvastatin calcium oral tablet 80 mg one tablet one time a day
- escitalopram oxalate tablet 20 mg 0.5 mg tablet one time a day
- ezetimibe tablet 10 mg one tablet at bedtime
- finasteride tablet 5 mg one tablet one time a day
- glipizide tablet 10 mg one tablet one time a day
- losartan potassium oral tablet 25 mg one tablet one time a day
- protonix tablet delayed release 40 mg one tablet one time a day
- sitagliptin phosphate tablet 50 mg one tablet one time a day
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 2 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
- carvedilol oral 6.26 mg, give 0.5 mg tablet two times a day
Level of Harm - Minimal harm
or potential for actual harm
Review of Resident 2's eMAR Medication Administration Note for November 2024 showed the following
medications were pending delivery:
Residents Affected - Few
- on 11/26/24 losartan potassium 25 mg pending delivery-new admission
- on 11/26/24 protonix delayed release 40 mg pending delivery-new admission
- on 11/26/24 sitagliptin phosphate 50 mg tablet pending delivery-new admission
- on 11/26/24 glipizide 10 mg tablet pending delivery-new admission
- on 11/26/24 escitalopram oxalate 20 mg pending delivery-new admission
- on 11/26/24 losartan potassium 25 mg pending delivery-new admission
- on 11/26/24 finasteride 5 mg pending delivery-new admission
- on 11/26/24 aspirin EC delayed release 81 mg pending delivery-new admission
- on 11/26/24 carvedilol 6.25 mg pending delivery-new admission
- on 11/26/24 alfuzosin HCl ER 10 mg pending delivery-new admission
- on 11/26/24 atorvastatin calcium 80 mg pending delivery-new admission
- on 11/27/24 ezetimibe 10 mg awaiting pharmacy delivery
- on 11/27/24 carvedilol 6.25 mg pending delivery
- on 11/27/24 atorvastatin calcium 80 mg pending delivery
- on 11/27/24 alfuzosin HCl ER 10 mg pending delivery
- on 11/27/24 protonix delayed release 40 mg pending delivery
- on 11/27/24 sitagliptin phosphate 50 mg tablet pending delivery
- on 11/27/24 glipizide 10 mg tablet pending delivery
- on 11/27/24 finasteride 5 mg pending delivery
- on 11/27/24 losartan potassium 25 mg pending delivery
- on 11/27/24 escitalopram oxalate 20 mg pending delivery-new admission
b. According to the Center for Disease Control and Prevention Managing Blood Sugar dated 5/2024
showed the blood sugar target before a meal range from 80-130 mg/dL and two hours after the start of a
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 3 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
meal should be less than 180 mg/dL.
Level of Harm - Minimal harm
or potential for actual harm
According to the Center for Disease Control and Prevention Your Brain and Diabetes dated 7/2024, your
brain is your body's command center. To do all its work, your brain uses sugar in your blood for energy. In
fact, the brain is the most energy-demanding organ. It needs half of all the sugar energy in the body to
function properly. If your blood sugar levels fall outside your normal range, it can throw your command
center off balance. In the same way diabetes can damage nerves in other parts of your body, it can damage
nerves in your brain. Having frequent episodes of high blood sugar (hyperglycemia) can stress the brain.
The effects of high blood sugar happen over time and aren't obvious right away. People often don't know
that their brain is being affected. High blood sugar over time damages blood vessels in the brain that carry
oxygen-rich blood. When your brain receives too little blood, brain cells can die. This can cause problems
with memory and thinking and eventually can lead to vascular dementia. Steps to improve or prevent
problems with brain health and diabetes, such as: keep your blood sugars within target levels and to take
medicine as prescribed.
Residents Affected - Few
Review of Resident 2's Care Plan showed the following focus and interventions:
- dated 12/2/24, at risk for elevated blood pressure related to HTN. The interventions included to give the
antihypertensive medication as ordered, monitor for the medication side effects, and report to MD as
necessary.
- dated 12/2/24, at risk for hypoglycemia/hyperglycemia r/t diabetes mellitus. The interventions included to
administer the diabetes medications as ordered, monitor/document for the side effects and effectiveness,
and educate regarding medications and importance of compliance.
- dated 12/2/24, resident has the potential for discomfort, complications related to benign prostatic
hyperplasia. The interventions include to administer the medications as ordered.
- dated 12/2/24, resident on escitalopram for depression. The interventions included to give the
antidepressant medications as ordered.
Review of Resident 2's Blood Sugar Summary dated on 12/2/24, showed a result of 514 mg/dL.
On 12/12/24 at 1425 hours, a concurrent interview and closed medical record review was conducted with
the DON. When asked if Resident 2 was on any blood sugar monitoring, the DON stated per the resident's
family member, he was not on the blood sugar monitoring at home. The DON stated for the respite care
residents, the facility uses the resident's home medications. When asked what the process was when
Resident 2 did not receive his medications on 11/26 and 11/27/24 and if the resident'sblood sugar would
have been monitored. The DON stated she was not aware Resident 2 did not receive his medications. The
DON stated the resident's family member was supposed to bring the medications for the resident. When
asked what the process was if the family member did not bring the medications timely, the DON stated, we
will order, and notify the resident's physician. When asked what 7 was in the MAR, the DON stated it meant
pending delivery. When asked who was responsible for following up for pending medication delivery, the
DON stated the charge nurses. When asked if it was documented the physician was notified regarding
Resident 2's medications had not been administered due to pending delivery, the DON stated, no not that I
can see. When asked if Resident 2's blood sugars levels were being monitored, the DON stated on 12/2/24,
Resident 2's blood sugar was checked prior to being sent out to the acute care facility. When asked why
Resident 2 was being sent out to the acute care facility, the DON stated Resident 2 was difficult to arouse,
and his oxygen saturation was 88%. When asked
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 4 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
what Resident 2's blood sugar result was on 12/2/24, the DON stated 514 mg/DL. When asked if that was a
high reading, the DON stated that's pretty high. The DON verified Resident 2's medications were not
administered on 11/26 and 11/27/24 due to pending delivery, and the physician was not notified the
medications were not administered as ordered due to pending medication delivery.
Residents Affected - Few
On 12/12/24 at 1638 hours, the DON and the Administrator Assistant acknowledged the above findings.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 5 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure that a nursing home area is free from accident hazards and provides adequate supervision to
prevent accidents.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, medical record review, facility P&P review, the facility failed to ensure three of nine
sampled residents (Residents 3, 4, and 5) remained free from accident hazards.
* Resident 3's fall risk care plan showed the interventions including for the resident's bed to be in the lowest
position and for the bilateral floor mats. However, the bed was not in the lowest position and the floor mat
was folded up against the wall.
* Resident 4's fall risk care plan addressing the resident's actual fall showed interventions including to
maintain a clear pathway, free of obstacles, needs a safe environment: floor free from spills and/or clutter.
However, the bedside table was placed on top of the floor mat next to the resident's bed.
* Resident 5's fall risk care plan addressing the resident's actual fall showed interventions including for the
resident's bed to be in the lowest position, for bilateral floor mats, and to maintain a clear pathway, free of
obstacles, needs a safe environment: floor free from spills and/or clutter. However, the bed was not in the
lowest position, and the bedside table was placed on top of the floor mat.
These failures had the potential to place the residents at risk for injury.
Findings:
Review of the facility's P&P titled Fall Management (undated) showed it is policy of this facility to investigate
the circumstances surrounding each resident's fall and implement actions to reduce incidences of
additional falls and minimize potential for injury. The care plan or an update to an existing care plan will then
be generated.
Review of the facility's P&P titled Fall Prevention revised 8/2020 showed toidentify the resident who are
high risk for fall, and if appropriate, interventions will be initiated per IDT member recommendation and
when necessary, physician's orders (i.e., physical therapy services, initiation, or medication of a device etc.)
for any fall related incident.
1. Medical record review for Resident 3 was initiated on 12/6/24. Resident 3 was admitted to the facility on
[DATE].
Review of Resident 3's H&P examination dated 6/28/24, showed Resident 3 had the capacity to understand
and make decisions.
Review of Resident 3's plan of care showed a care plan problem initiated on 7/5/24, addressing risk for
further falls. The interventions included floor mats at bedside and bed in lowest position.
Review of Resident 3's Fall Risk Evaluation dated 9/24/24, showed Resident 3's score was 14 which was
categorized as high risk for falls.
On 12/6/24 at 0955 hours, an observation was made of Resident 3's bed and floor mats. The
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 6 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
right-side floor mat was observed folded up against the wall and the bed was not in the lowest position.
Level of Harm - Minimal harm
or potential for actual harm
On 12/6/24 at 1003 hours, a concurrent observation and interview was conducted with the DON. The DON
verified Resident 3's right-side floor mat was folded up against the wall and stated Resident 3's care plan
interventions included for the bilateral floor mats.
Residents Affected - Few
On 12/6/24 at 1010 hours, a concurrent observation and interview was conducted with the Administrator.
The Administrator acknowledged the right-side floor mat was against the wall. When asked if Resident 3's
bed was at the lowest position, the Administrator went to check, and the bed went down another inch.
2. Medical record review for Resident 4 was initiated on 12/6/24. Resident 4 was admitted to the facility on
[DATE].
Review of Resident 4's H&P examination dated 11/14/24,showed Resident 4 had no capacity to understand
and make decisions.
Review of Resident 4's plan of care addressing the resident's actual fall initiated on 11/13/24, showed
interventions including to maintain a clear pathway, free of obstacles, needs a safe environment, floors free
from spills, and/or clutter.
On 12/6/24 at 1629 hours, an observation was made of Resident 4's bedside table that was placed on top
floor mat on the left side of the bed, and one end of the floor mat was observed to be flipped up.
On 12/6/24 at 1639 hours, a concurrent observation and interview was conducted with RN 1. RN 1 verified
Resident 4's bedside table was on top of the floor mat and stated, feels more like a fall risk because she
gets up so much. RN 1 stated she observed the floor mat was flipped up, and the table was on top of the
floor mat.
3. Medical record review for Resident 5 was initiated on 12/12/24. Resident 5 was admitted to the facility on
[DATE].
Review of Resident 5's plan of care showed a care plan problem initiated on 10/24/24,addressing the actual
fall. The care plan showed interventions including for thebed to be in the lowest position, bilateral floor mats,
maintain a clean pathway, needs a safe environment: floor free from spills, and/or clutter.
Review of Resident 5's H&P examination dated 10/26/24. Resident 5 had the capacity understand and
make decisions.
On 12/12/24 at 0834 hours, Resident 5's bed was observed not in the lowest position and on the left side of
the bed, the bedside table was observed on top of the floor mat.
On 12/12/24 at 0839 hours, a concurrent observation and interview was conducted with CNA 2. Upon
entering Resident 5's room, CNA 2 was asked if Resident 5's bed was in the lowest position. CNA 2 moved
the bedside table from off the floor mat to reach the remote control for the bed control. When asked if the
bed was in the lowest position, the CNA 2 lowered the bed further with the remote control.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 7 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
Level of Harm - Minimal harm
or potential for actual harm
CNA 2 stated the bed was not in the lowest position, and acknowledged he moved the bedside table that
was on top of the floor mat.
On 12/12/24 at 1425 hours, an interview was conducted with the DON. When asked if the bedside table
should be placed on top of the floor mats, the DON stated, it shouldn't be there.
Residents Affected - Few
On 12/12/24 at 1638 hours, the DON and the Administrator Assistant acknowledged the above findings.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 8 of 9
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055689
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/12/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St. Catherine Healthcare
245 E Wilshire Avenue
Fullerton, CA 92832
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Potential for
minimal harm
Residents Affected - Some
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview, medical record review, and the facility's P&P review, the facility failed ensure the accuracy of the
MAR for one of nine sampled residents (Resident 2). This failure had the potential for the resident's care
needs not being met.
Findings:
Review of the facility's P&P titled Documentation dated 5/2007 showed the resident's clinical record is
concise and accurate account of treatment, care, response to care, signs, symptoms, and progress of the
resident's condition.
Closed medical record review for Resident 2 was initiated on 12/6/24. Resident 2 was admitted to the
facility on [DATE],for respite care and was transferred to theacute care facility on 12/2/24.
Review of Resident 2's H&P examination dated 11/26/24, showed Resident 2 had fluctuating capacity to
understand and make decisions.
Review of Resident 2's Order Summary Report dated 11/25/24, showed to administer carvedilol oral tablet
6.25 mg-give 0.5 mg by mouth two times a day for hypertension and ezetimibe tablet 10 mg-give one tablet
by mouth at bedtime for HLD.
Review of Resident 2's eMAR Medication Administration Note for November 2024 showed:
- on 11/26/24 carvedilol 6.25 mg was documented as pending delivery-new admission
- on 11/27/24 carvedilol 6.25 mg was documented as pending delivery
- on 11/27/24 ezetimibe 10 mg showed awaiting pharmacy delivery
However, review of Resident 2's Medication Administration Record for November 2024 showed the
following medications were administered:
- on 11/26/24 at 1700 hours, carvedilol 6.25 mg
- on 11/26/24 at 2100 hours, ezetimibe 10 mg
On 12/12/24 at 1425, a concurrent interview and closed medical review was conducted with the DON. The
DON verified Resident 2's medications that were pending delivery were not administered and were error in
the documentation as administered.
On 12/12/24 at 1638 hours, the DON and the Administrator Assistant acknowledged the findings.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055689
If continuation sheet
Page 9 of 9